Clinical studies have demonstrated that CCA displays a distinct propensity for metastasis to the liver.[21] A liver metastasis model of spleen‐injected CCA cells was constructed to assess the effect of TET1 on liver metastasis in vivo. This evidence concerns the gene TET1 and cholangiocarcinoma.